Bladder Cancer: Chemoprevention, complementary approaches and budgetary considerations

Authors: Grossman, H. Barton¹; Stenzl, Arnulf²; Moyad, Mark³; Droller, Michael⁴

Source: Scandinavian Journal of Urology and Nephrology, Volume 42, Supplement 218, September 2008 , pp. 213-233(21)

Buy & download fulltext article:

Price: $34.29 plus tax (Refund Policy)

Abstract:

Bladder cancer results from complex and only partially understood host-environmental interactions. Tobacco smoking is the greatest risk factor for bladder cancer, but the actual risk to an individual reflects not only the amount of exposure to the carcinogens in tobacco smoke but also host susceptibility to these carcinogens and possibly other factors. Lifestyle may have a significant effect on the incidence of this disease. The forms of chemoprevention and their relevance to bladder cancer, the impact of lifestyle and complementary medicine, and the costs of diagnosing and treating bladder cancer are reviewed to provide a base for advances in decreasing the incidence, recurrence and costs of this disease.

Keywords: Bladder cancer; chemoprevention; complementary medicine; costs; lifestyle

Document Type: Research article

DOI: http://dx.doi.org/10.1080/03008880802284258

Affiliations: 1: University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA 2: Eberhard-Karls-University Tuebingen, Tuebingen, Germany 3: University of Michigan Medical Center, Ann Arbor, Michigan, USA 4: Mount Sinai Medical Center, New York, New York, USA

Publication date: 2008-09-01

More about this publication?